START-Midwest — Grand Rapids, Michigan

START-Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49503.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

START-Midwest has participated in 1 clinical trials.

Therapeutic areas: Metastatic Cancer, Solid Tumor, Advanced Cancer.

Sponsors: ALX Oncology Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START-Midwest?

START-Midwest has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START-Midwest conducted?

START-Midwest has 1 clinical trials on record. Their work covers Metastatic Cancer, Solid Tumor, Advanced Cancer.

Is START-Midwest accredited by Crixeo Health?

START-Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START-Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.